OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
43
Results
Show all
Save search
Copy query
Show results for
Unknown
(43)
Publication Date
Release Date
2021
(11)
2022
(7)
2023
(6)
2025
(4)
2015
(3)
2024
(2)
2020
(2)
2012
(2)
2009
(2)
2017
(1)
2016
(1)
2010
(1)
2008
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study.
Not available
S-EPMC10471658
|
biostudies-literature
Cite
Translating medication effects for alcohol use disorder across preclinical, human laboratory, and clinical trial outcomes using meta-analysis.
Not available
S-EPMC12279940
|
biostudies-literature
Cite
Trauma-informed Collaborative Care for African American Primary Care Patients in Federally Qualified Health Centers: A Pilot Randomized Trial.
Not available
S-EPMC8867914
|
biostudies-literature
Cite
Testing an Intervention to Improve Health Care Worker Well-Being During the COVID-19 Pandemic: A Cluster Randomized Clinical Trial.
Not available
S-EPMC11061774
|
biostudies-literature
Cite
Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.
Not available
S-EPMC4818564
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
Not available
S-EPMC8362592
|
biostudies-literature
Cite
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594
|
biostudies-literature
Cite
UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
Not available
S-EPMC3423010
|
biostudies-literature
Cite
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.
Not available
S-EPMC4469977
|
biostudies-literature
Cite
Levels of soluble complement regulators predict severity of COVID-19 symptoms.
Not available
S-EPMC9624227
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets